HC Wainwright & Co. Initiates Coverage On Perspective Therapeutics with Buy Rating, Announces Price Target of $10

Benzinga · 03/13 10:22
HC Wainwright & Co. analyst Robert Burns initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Buy rating and announces Price Target of $10.